Their analysis of the data of 20,424 hypertensive adults enrolled in the China Stroke Primary Prevention Trial observed that in Chinese hypertensive patients, the effect of Hcy on the first stroke was significantly modified by the methylenetetrahydrofolate reductase C677T genotype and folic acid supplementation. This evidence concerns the gene MTHFR and stroke disorder.